Your browser doesn't support javascript.
loading
Microfluidic-based dynamic BH3 profiling predicts anticancer treatment efficacy.
Manzano-Muñoz, Albert; Yeste, José; Ortega, María A; Martín, Fernando; López, Anna; Rosell, Jordi; Castro, Sandra; Serrano, César; Samitier, Josep; Ramón-Azcón, Javier; Montero, Joan.
Afiliação
  • Manzano-Muñoz A; Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Yeste J; Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Ortega MA; Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Martín F; Vitala Technologies, Barcelona, Spain.
  • López A; Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Rosell J; Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain.
  • Castro S; Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
  • Serrano C; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Samitier J; Surgical Oncology Division, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Ramón-Azcón J; Sarcoma Translational Research Program, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Montero J; Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
NPJ Precis Oncol ; 6(1): 90, 2022 Dec 01.
Article em En | MEDLINE | ID: mdl-36456699

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha